Arrayed Dead End Bank (ADEB):
This bank contains breast
cancer samples that were reconstituted into paraffin blocks from pulverized
frozen tissue. There is no clinical, pathological or follow-up information
about any of these tumors. They were originally collected between 1987
and 1998 for the NBCTR. As such, they can be requested by SPORE investigators.
There are 89 12-tumor arrays in this bank. The first 12 arrays contain in situ tumors and are released sparingly. Arrays 13-89 contain all histologies of infiltrating breast cancers. This resource is quite limited. The paraffin blocks in which these arrays are embedded are currently managed by the Pathology Core under D. Craig Allred, M.D. The quality control for all of these tissues was performed by D Craig Allred.
Arrayed Follow-up Bank (AFUB):
This bank contains breast
cancer samples that were reconstituted into paraffin blocks from pulverized
frozen tissue. They were originally collected between 1973 and 1993 for
the MOPP and SPORE tumor banks. There are more MOPP tumors than SPORE tumors
in this bank (these are the remains of the Node Positive and Node Negative
Banks). The arrays are available only to Breast Center investigators and
their collaborators. All of the tumors are those of patients who were abstracted
and followed via one of the two old databases (oldMOPP, commonly referred
to as the San Antonio database, and oldSPORE, commonly called the Nichols
database). They consist of in
situ and infiltrating breast carcinomas.
There are 133 12-specimen arrays in this bank. Though the arrays contain mostly followed breast cancer tumors, there are other tissues set on the arrays for control purposes (breast cancers without followup and normal tissues). The paraffin blocks in which these arrays are embedded are currently managed by the Pathology Core under D. Craig Allred, M.D. The quality control for all of these tissues was performed by D Craig Allred.
TransATAC (TA-01):
This bank contains specimens from
patients enrolled in the Arimidex, Tamoxifen and Combination clinical trial.
The Breast Center is creating and storing these samples for the international
ATAC Committee, and cannot dispense them for research. Any requests for
these samples must be addressed to the Pathology Subcommittee for the ATAC
clinical trial. The samples are managed by Leslie Lopez.
oldMOPP/San Antonio Inventory:
FROZEN-This is tissue
that was flash frozen at various hospitals around the U.S. It was pulverized
for ligand-binding assay and flow cytometry, and the residual was kept
at –70 degrees in vials. It has to be warmed
to be aliquotted, so some samples have been warmed multiple times for short
periods. In June 2000, all power was cut off to the freezers for a period
of at least 48 hours, and most of the vials spent that time in hot water.
They have been refrozen, but of course their utility is now severely limited.
These tumors were collected between 1970 and 1999 (most were collected before 1986) for ER/PgR and s-phase/ploidy assays. They were followed until 12/31/2002, when the old MOPP grant expired. More than half of the patients were from San Antonio and outlying towns in Texas, but a significant proportion came from different parts of the country: upstate New York, New Orleans (LA), Cleveland (OH) and other places. There are some powders left, but now most of them have been used. These tumors are managed by Bryant McCue.
PARAFFIN-Small portions of certain patients’ tumors (those patients whose frozen tumors were included in the Node Negative and Node Positive subbanks of the MOPP inventory) were converted into fixed paraffin-block specimens. A slide was read from each block, and information about the quality of the sample (assessed by Drs. Allred, Yu, and Libby) was entered into the database.
SPORE/NBCTR (National Breast Cancer Tissue Resource):
FROZEN-This
tissue was flash frozen at various hospitals around the U.S. It was pulverized
for ligand-binding assay and flow cytometry, and the residual was kept
at –70 degrees in vials. It has to be warmed to
be aliquotted, so some samples have been warmed multiple times for short
periods. In June 2000, all power was cut off to the freezers for a period
of at least 48 hours, and most of the vials spent that time in hot water.
They have been refrozen, but of course their utility is now severely limited.
These tumors were collected between 1984 and 1999 for ER/PgR and s-phase/ploidy assays through the Nichols Institute Reference Laboratories (now Quest Diagnostics). They were followed until 12/31/2002, when the old SPORE grant expired. The patients were from different parts of the U.S., mostly California (39,034) and Texas (26, 181). There are some powders left, but not most of them have been used or were thrown away after the tropical storm in June 2000. Those which were kept after 6/00 were all frozen specimens from followed patients, patients whose tumors were used in a prior large study, and/or tumors that were suspected of being from the same patient (bilateral primaries, contralateral primaries and recurrent lesions). These tumors are managed by Bryant McCue.
PARAFFIN-Small portions of certain patients’ tumors (the ‘spore bank’ subset, which were the tumors with the best (cleanest) clinical and followup data in the nichols database) were converted into fixed paraffin-block specimens. A slide was read from each block, and information about the quality of the sample (assessed by Drs. Allred, Yu, and Libby) was entered into the database.
Ben Taub Breast Tissue Resource:
This resource is a collection
of breast tissue (normal, premalignant and malignant) harvested at Ben
Taub in the Harris County Hospital District. The patients have been diagnosed
after 2000. Retrospective samples (paraffin blocks) will be collected for
as many patients as possible. Prospective samples (flash-frozen in liquid
nitrogen in the frozen section room at the time of surgery) are being collected
for as many patients as possible after 11/2003. There will be associated
followup with these samples, and followup is planned indefinitely. These
tissues will be available to Breast Center investigators. This resource
is managed by Bryant McCue.
Asterand Breast Tumor Bank:
The patients who contributed
these tumors were diagnosed between 1975 and 1983 at several different
sites in Detroit, Michigan. They were collected by the Michigan Cancer
Foundation as part of a study of prognostic factors. The tumors were transferred
to the Breast Center at Baylor College of Medicine when the currently-named
Karmanos Cancer Center no longer had the funding to maintain the tumors
and data. There is associated followup with these tumors, though the subjects
and their tumors have been anonymized. This Bank may be utilized by Breast
Center and other SPORE investigators.
FROZEN: The frozen samples are solid pieces of flash-frozen tissue. A small subset were frozen in OCT, but the majority were frozen using liquid.
PARAFFIN: At the time of surgery, half of the specimen not needed for diagnostic purposes was flash-frozen, while the other half was formalin-fixed and preserved in paraffin blocks. These are also solid tissue. This resource is managed by Bryant McCue.
Metastatic Tissue Bank:
This protocol proposes to collect
tissue from metastases from breast primaries when they are biopsied. An
extra core or two will be harvested and flash-frozen in the clinic, and
paraffin blocks will also be collected after diagnosis is complete. There
will be limited associated followup with these cases, maintained by Dr.
Elledge’s research nurse. This
resource is managed by Bryant McCue.
The RAHBT (referred to as “Rabbit”—“Repository
of Archival Human Breast Tissue”):
The bank is the repository of all paraffin
blocks of breast cancer patients whose breast tissue resides at Texas Methodist
Hospital. The overall RAHBT is not a tumor bank—no specimens can
be requested from it, though there are sub-banks in the RAHBT which can
be accessed for research with the proper IRB and Tissue Use Committee approval.
There are already 2 banks in the RAHBT which have been IRB-approved and
are available for research requests (within their own limits): the Evolutionary
Bank and the Garrett R. Lynch Tissue Resource. Due to certain political
problems, no paraffin blocks may be requested at this time.
Evolutionary Bank (sub-bank of RAHBT):
D. Craig Allred
began collecting tissue for this resource in c. July
1999, and continued to collect tissue specimens when they became available
until about 2004. All of the specimens in this bank are very small. They
are not breast malignancies; rather, they range from normal breast tissue
through abnormal breast tissue and to pre-cancerous lesions. These lesions
are managed by Craig Allred.
Garrett R. Lynch Tissue Resource (GRL/Retrospective) (sub-bank
of RAHBT):
Begun in 2001, this resource is a retrospective study
of breast cancer patients treated by Garrett R. Lynch. This was planned
as exclusively a paraffin block resource, as it is entirely retrospective.
All patients whose blocks are in this resource will be followed. The
paraffin blocks have not been collected yet, but if they do join the
inventory, they will be managed by Bryant McCue.
These specimens (called “proteins”) were derived from subsets of the Node Negative and Node Positive banks in the MOPP (which did contain some SPORE tumors, but not many). This was done in the mid 1990's by Suzanne Fuqua . They are stored frozen, in vials. They are not aliquoted—when somebody needs them, Irma Parra thaws them and measures out approximately 20 mg of each protein for the requestor. The WB freezer did not warm up significantly during the 6/00 power outage. There are very few proteins in this resource.
The NSABP Serum Bank:
Comprised of sera from patients
enrolled in all NSABP clinical trials performed since 1999. The Breast
Center acts as a skilled storage facility for these samples, and cannot
dispense them for research. Any requests for these samples must be addressed
to the NSABP. The samples are managed by Bryant McCue.